Announcement on the Redemption of Nanjing Pharmaceutical's 2025 Phase II Short-Term Financing Bonds

Nanjing Pharmaceutical Co., Ltd. issues a public announcement regarding the redemption of the second tranche of super short-term financing bonds in 2025. The issuance amount of the bond is 500 million yuan, with an interest start date of March 17, 2025, a term of 179 days, a bond interest rate of 1.94% for the period, and a redemption date of September 12, 2025. The total amount of principal and interest to be repaid in this period is 504.757 million yuan. The lead underwriter and ongoing management institution is Hangzhou Bank, and the registration custody institution is China Foreign Exchange Trading Center.